These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17901939)

  • 1. [Immunoglobulins in primary antibody deficiency: should they also be used in sepsis and other indications?].
    Kluge S; de Heer G; Nierhaus A; Kreymann G
    Internist (Berl); 2007 Nov; 48(11):1297-302, 1304. PubMed ID: 17901939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravenous substitution with immunoglobulins].
    Zielinski CC; Eibl MM
    Wien Klin Wochenschr; 1991; 103(17):524-7. PubMed ID: 1949811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin: new clinical applications.
    Steele RW; Burks AW; Williams LW
    Ann Allergy; 1988 Feb; 60(2):89-94. PubMed ID: 2829663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and therapy with immunoglobulin SRK].
    Schnoz M; Ryser DH; Barandun S; Eckmann L
    Helv Chir Acta; 1979 May; 46(1-2):111-3. PubMed ID: 38227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies.
    Cinetto F; Neri R; Vianello F; Visentin A; Barilà G; Gianese S; Lanciarotta A; Milito C; Rattazzi M; Piazza F; Trentin L; Zambello R; Agostini C; Scarpa R
    PLoS One; 2021; 16(3):e0247717. PubMed ID: 33661940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary antibody deficiency.
    Duraisingham SS; Buckland MS; Grigoriadou S; Longhurst HJ
    Expert Rev Clin Immunol; 2014 May; 10(5):583-91. PubMed ID: 24684706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic use of human immunoglobulins in immune deficiencies].
    Touraine JL
    Arch Fr Pediatr; 1982; 39 Suppl 1():569-72. PubMed ID: 7159180
    [No Abstract]   [Full Text] [Related]  

  • 8. [New indications for gamma globulins].
    Fontán G; García MC; Pascual-Salcedo D; López Trascasa M; Alvarez Doforno R; Ferreira A
    An Esp Pediatr; 1992 Jun; 36 Suppl 48():135-8. PubMed ID: 1379010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical use of polyvalent immunoglobulin preparations].
    Zimmermann S; Liebert A
    Z Gesamte Inn Med; 1988 Dec; 43(24):711-2. PubMed ID: 3070976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin Replacement Therapy for Primary Immunodeficiency.
    Sriaroon P; Ballow M
    Immunol Allergy Clin North Am; 2015 Nov; 35(4):713-30. PubMed ID: 26454315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current applications of immunoglobulin therapy].
    Helmke K
    Fortschr Med; 1994 May; 112(15):213-7. PubMed ID: 8050765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin, immunodeficiency syndromes and idiopathic thrombocytopenic purpura. Proceedings of a workshop. Edinburgh, Scotland, 4 and 5 December 1986.
    J Infect; 1987 Jul; 15 Suppl 1():1-65. PubMed ID: 3117895
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
    Kreymann KG; de Heer G; Nierhaus A; Kluge S
    Crit Care Med; 2007 Dec; 35(12):2677-85. PubMed ID: 18074464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gammaplex
    Wasserman RL
    Immunotherapy; 2017 Oct; 9(13):1071-1088. PubMed ID: 29032734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous immunoglobulins. Basic principles, selection criteria and indications for preventive and therapeutic administration].
    Böger RH; Bode-Böger SM; Frölich JC
    Med Klin (Munich); 1995 Sep; 90(9):520-6. PubMed ID: 7476730
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies.
    Wolf HH; Davies SV; Borte M; Caulier MT; Williams PE; Bernuth HV; Egner W; Sklenar I; Adams C; Späth P; Morell A; Andresen I
    Vox Sang; 2003 Jan; 84(1):45-53. PubMed ID: 12542733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of immunoglobulins in adults in a university hospital: a retrospective study.
    Farber CM; Van der Biest-Cardinal C
    Acta Clin Belg; 2011; 66(6):416-8. PubMed ID: 22338302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].
    Pac M
    Pol Merkur Lekarski; 2011 Jun; 30(180):413-6. PubMed ID: 21751550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insurance.
    Högy B; Keinecke HO; Borte M
    Eur J Health Econ; 2005 Mar; 6(1):24-9. PubMed ID: 15480920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Practical comments on the use of immunoglobulins].
    Lewandowicz-Uszyńska A; Swierkot J
    Pol Merkur Lekarski; 2011 Jun; 30(180):448-51. PubMed ID: 21751557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.